Xl Precision Technologies Ltd.

Based in the UK, Xl Precision Technologies Ltd. specializes in precision manufacturing solutions designed for the medical device industry, delivering high-quality components and sub-assemblies for various healthcare applications. Xl Precision Technologies Ltd. was founded in 1998 and operates as a subsidiary of Elevaris Medical Devices.

The company focuses on the precision manufacturing of components for the medical device sector. Colin Thompson, the founder, has a history of entrepreneurship, although details on other ventures are not available. The company has engaged in two notable funding deals, with the most recent deal occurring on September 30, 2024. Xl Precision Technologies provides a comprehensive array of precision manufacturing solutions tailored for the medical device industry.

Their offerings include the production of precision micro-components, complex tubular components, and sub-assemblies vital for applications such as cardiovascular devices, endoscopy, and drug delivery systems. Utilizing advanced manufacturing technologies like laser machining and electrical discharge machining (EDM), they produce components that adhere to strict industry standards. Their client base largely consists of medical device manufacturers across North America, Europe, and Asia-Pacific, while their products serve healthcare providers and patients seeking innovative medical solutions. In the most recent fiscal year, Xl Precision Technologies reported a revenue of USD 7.

22 mn and an EBITDA of USD 659,127. 4. The company's revenue model is based on B2B transactions with medical device manufacturers, entering into contracts that facilitate customized manufacturing services tailored to client specifications. Following its acquisition by Spectra Medical Devices, LLC on September 30, 2024, Xl Precision Technologies plans to enhance its production capacity and streamline its product development processes.

The acquisition will support the design and launch of new products within the medical device sector, although specific release dates for upcoming products have not been disclosed. The company aims to expand its market reach, particularly in North America and Europe, leveraging the resources and capabilities of the newly formed parent company.